EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of Brucella abortus Mutant A19mut2, a Potential DIVA Vaccine Candidate with a Modification on Lipopolysaccharide

Hosny Ahmed Abdelgawad iD, Zhengmin Lian, Yi Yin, Tian Fang, Mingxing Tian, Shengqing Yu

Vaccines · 21.07.2023 · 11 (7) · 1273

DOI: 10.3390/vaccines11071273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 21.07.2023. Verfasst von Hosny Ahmed Abdelgawad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Shanghai 200241, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, The Scientific and Technical Innovation Project of the Chinese Academy of Agricultural Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brucella abortus is the main causative agent for bovine brucellosis. B. abortus A19 is a widely used vaccine strain to protect cows from Brucella infection in China. However, A19 has a similar lipopolysaccharide (LPS) antigen to that of the field virulent Brucella strain, whose immunization interferes with the serodiagnosis of vaccinated and infected animals. [Aim] To develop a novel Brucella DIVA vaccine candidate. Study design and methods: The B. abortus mutant A19mut2 with the formyltransferase gene wbkC is replaced by an acetyltransferase gene wbdR from E. coli O157 using the bacterial homologous recombination technique, generating a modified O-polysaccharide that cannot induce antibodies in mice against wild-type Brucella LPS. The biological phenotypes of the A19mut2 were assessed using a growth curve analysis, agglutination tests, Western blotting, and stress resistance assays. Histopathological changes and bacterial colonization in the spleens of vaccinated mice were investigated to assess the residual virulence and protection of the A19mut2. Humoral and cellular immunity was evaluated by measuring the levels of IgG, IgG subtypes, and the release of cytokines IFN-γ and IL10 in the splenocytes of the vaccinated mice. ELISA coated with wild-type LPS can distinguish mouse antibodies induced by A19 and A19mut2 immunization.

Results

The A19mut2 showed a decreased residual virulence in mice, compared to the A19 strain, but induced significant humoral and cellular immune responses, as the A19 immunization did. The protection efficacy of A19mut2 immunization against B. abortus S2308 NalR infection was similar to that of A19 immunization.

Conclusion

The A19mut2 has potential as a novel DIVA vaccine candidate in the future.

Schlagwörter

Stichwörter der Autor:innen

Brucella abortusdifferential diagnosislipopolysaccharidemodificationvaccine

Autor:innen und Institutionen

  • Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Shanghai 200241, China.
  • Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Aswan University, Aswan 81528, Egypt.
  • Jiangsu Key Laboratory for High-Tech Research and Development of Veterinary Biopharmaceuticals, Jiangsu Agri-Animal Husbandry Vocational College, Veterinary Bio-Pharmaceutical, Taizhou 225309, China.

ORCID-Profile: Hosny Ahmed Abdelgawad

Förderung

  • The National Natural Science Foundation of China
  • The Scientific and Technical Innovation Project of the Chinese Academy of Agricultural Sciences
  • National Natural Science Foundation of China
  • Scientific and Technical Innovation Project of the Chinese Academy of Agricultural Sciences

Zitieren

APA

Abdelgawad, H. A., Lian, Z., Yin, Y., Fang, T., Tian, M., & Yu, S. (2023). Characterization of Brucella abortus Mutant A19mut2, a Potential DIVA Vaccine Candidate with a Modification on Lipopolysaccharide. Vaccines, 11(7), 1273. https://doi.org/10.3390/vaccines11071273

Vancouver

Abdelgawad HA, Lian Z, Yin Y, Fang T, Tian M, Yu S. Characterization of Brucella abortus Mutant A19mut2, a Potential DIVA Vaccine Candidate with a Modification on Lipopolysaccharide. Vaccines. 2023;11(7):1273. doi:10.3390/vaccines11071273

BibTeX
@article{Abdelgawad2023,
  author = {Abdelgawad, Hosny Ahmed and Lian, Zhengmin and Yin, Yi and Fang, Tian and Tian, Mingxing and Yu, Shengqing},
  title = {Characterization of Brucella abortus Mutant A19mut2, a Potential DIVA Vaccine Candidate with a Modification on Lipopolysaccharide},
  journal = {Vaccines},
  year = {2023},
  volume = {11},
  number = {7},
  pages = {1273},
  doi = {10.3390/vaccines11071273}
}
Kostenlos starten →